Deferasirox
- Product NDC
- 72606-014
- 11-digit product format
- 726060014
- Labeler code
- 72606
- Product ID
- 72606-014_c05685c0-576c-4259-8621-8aa9d9a971c1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- CELLTRION USA, INC.
- Application
- ANDA212669
- Marketing category
- ANDA
- Marketing start
- 2021-06-08
- Marketing end
- 0000-00-00
- Substance
- DEFERASIROX
- Active strength
- 180 mg/1
- Pharmacologic classes
- Iron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72606-014-01 | 72606001401 | 30 TABLET, FILM COATED in 1 BOTTLE (72606-014-01) | 2021-06-08 | 0000-00-00 | No | No | Current |